{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["5(5)"],"submitter":["Cooper DM"],"pubmed_abstract":["<h4>Background</h4>Malignant ureteral obstruction (MUO) is a frequent challenge for urologists. Patients have poor prognoses, treatment aims to improve quality-of-life while optimising renal function. Standard practice in the United Kingdom is to use polyurethane stents, which require frequent surgical replacements for blockages and encrustation. More durable metallic stents are available, although these incur an increased initial purchase price.<h4>Aims</h4>We aim to assess whether the use of polyurethane double-J (JJ) or metallic stent, Resonance® is more cost-effective for managing MUO in the UK healthcare setting.<h4>Methods</h4>A Markov model was parameterised to 5 years with costs and health-related quality-of-life consequences for treating MUO with Resonance metallic stent (Cook Med"],"journal":["BJUI compass"],"pagination":["465-475"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC11090770"],"repository":["biostudies-literature"],"pubmed_title":["Cost-effectiveness of Resonance® metallic ureteral stent compared with standard polyurethane ureteral stents in malignant ureteric obstruction: A cost-utility analysis."],"pmcid":["PMC11090770"],"pubmed_authors":["Lines R","Shergill I","Cooper DM"],"additional_accession":[]},"is_claimable":false,"name":"Cost-effectiveness of Resonance® metallic ureteral stent compared with standard polyurethane ureteral stents in malignant ureteric obstruction: A cost-utility analysis.","description":"<h4>Background</h4>Malignant ureteral obstruction (MUO) is a frequent challenge for urologists. Patients have poor prognoses, treatment aims to improve quality-of-life while optimising renal function. Standard practice in the United Kingdom is to use polyurethane stents, which require frequent surgical replacements for blockages and encrustation. More durable metallic stents are available, although these incur an increased initial purchase price.<h4>Aims</h4>We aim to assess whether the use of polyurethane double-J (JJ) or metallic stent, Resonance® is more cost-effective for managing MUO in the UK healthcare setting.<h4>Methods</h4>A Markov model was parameterised to 5 years with costs and health-related quality-of-life consequences for treating MUO with Resonance metallic stent (Cook Med","dates":{"release":"2024-01-01T00:00:00Z","publication":"2024 May","modification":"2026-03-27T16:37:13.081Z","creation":"2025-08-27T03:08:54.311Z"},"accession":"S-EPMC11090770","cross_references":{"pubmed":["38751954"],"doi":["10.1002/bco2.332"]}}